support@nanobiousa.com
1-888-678-8889 (USA)
| Product Name | Size | Catalog No. |
|---|---|---|
3WJ-RFA(TNBC)-antiMIR17Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Triple Negative Breast Cancer ( TNBC) cells and antiMIR17 |
1nmol | RNP-M17-01-1 |
| 50nmol | RNP-M17-01-2 | |
3WJ-RFA(PC)-antiMIR17Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Prostate Cancer (PC ) cells and antiMIR17 |
1nmol | RNP-M17-02-1 |
| 50nmol | RNP-M17-02-2 | |
3WJ-RFA(HER2)-antiMIR17Serum stable 3WJ RNA Nanoparticle with an aptamer targeting HER2 + cancer cells and antiMIR17 |
1nmol | RNP-M17-03-1 |
| 50nmol | RNP-M17-03-2 | |
3WJ-RFA(EC)-antiMIR17Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Epithelial Cancer (EC) cells and antiMIR17 |
1nmol | RNP-M17-04-1 |
| 50nmol | RNP-M17-04-2 | |
3WJ-RFC(FA)-antiMIR17Serum stable 3WJ RNA Nanoparticle with a folate ligand for targeting folate receptor (+) cells and antiMIR17 |
1nmol | RNP-M17-05-1 |
| 50nmol | RNP-M17-05-2 | |
3WJ-RFC(GL)-antiMIR17Serum stable 3WJ RNA Nanoparticle with a galactose ligand for targeting liver cancer cells and antiMIR17 |
1nmol | RNP-M17-06-1 |
| 50nmol | RNP-M17-06-2 | |
3WJ-RFM-antiMIR17Serum stable 3WJ RNA Nanoparticle with a mutant aptamer (serving as a targeting control) and antiMIR17 |
1nmol | RNP-M17-07-1 |
| 50nmol | RNP-M17-07-2 | |
3WJ-RF-antiMIR17Serum stable 3WJ RNA Nanoparticle without ligand (serving as vector control) an but with antiMIR17 |
1nmol | RNP-M17-08-1 |
| 50nmol | RNP-M17-08-2 |
